Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2023
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer
Alban Bessede, Florent Peyraud, Sylvestre Le Moulec, et al.
Molecular Cancer
|
February 20, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide
Maud Toulmonde, Jean-Philippe Guegan, Mariella Spalato-Ceruso, et al.
British Journal of Haematology
|
May 7, 2022
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse
Luc Heraudet, Jean Galtier, Simon Favre, et al.
Signal Transduction and Targeted Therapy
|
June 27, 2025
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab
Maud Toulmonde, Jean-Philippe Guégan, Mariella Spalato-Ceruso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung Cancer
Alban Bessede, Florent Peyraud, Benjamin Besse, et al.
Molecular Cancer
|
February 19, 2024
Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study
Cheng-Ming Sun, Maud Toulmonde, Mariella Spalato-Ceruso, et al.
Cancer Medicine
|
June 3, 2021
Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME
Thomas Chevalier, Amaury Daste, Esmaa Saada-Bouzid, et al.
Cell Reports. Medicine
|
February 5, 2025
Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures
Florent Peyraud, Jean-Philippe Guégan, Christophe Rey, et al.
Cell Reports. Medicine
|
November 26, 2024
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response
Jean-Philippe Guégan, Florent Peyraud, Bérengère Dadone-Montaudie, et al.
Cell Reports
|
June 19, 2026
Immunosuppressive myeloid cells induce mesenchymal-like breast cancer stem cells by a membrane-bound TGF-β1-dependent mechanism
Thomas Boyer, Céline Blaye, Domitille Chalopin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2023
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer
Alban Bessede, Florent Peyraud, Sylvestre Le Moulec, et al.
Molecular Cancer
|
February 20, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide
Maud Toulmonde, Jean-Philippe Guegan, Mariella Spalato-Ceruso, et al.
British Journal of Haematology
|
May 7, 2022
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse
Luc Heraudet, Jean Galtier, Simon Favre, et al.
Signal Transduction and Targeted Therapy
|
June 27, 2025
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab
Maud Toulmonde, Jean-Philippe Guégan, Mariella Spalato-Ceruso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung Cancer
Alban Bessede, Florent Peyraud, Benjamin Besse, et al.
Molecular Cancer
|
February 19, 2024
Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study
Cheng-Ming Sun, Maud Toulmonde, Mariella Spalato-Ceruso, et al.
Cancer Medicine
|
June 3, 2021
Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME
Thomas Chevalier, Amaury Daste, Esmaa Saada-Bouzid, et al.
Cell Reports. Medicine
|
February 5, 2025
Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures
Florent Peyraud, Jean-Philippe Guégan, Christophe Rey, et al.
Cell Reports. Medicine
|
November 26, 2024
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response
Jean-Philippe Guégan, Florent Peyraud, Bérengère Dadone-Montaudie, et al.
Cell Reports
|
June 19, 2026
Immunosuppressive myeloid cells induce mesenchymal-like breast cancer stem cells by a membrane-bound TGF-β1-dependent mechanism
Thomas Boyer, Céline Blaye, Domitille Chalopin, et al.
Page
of 2